Trusted advisors?

DZP advises OW Proton on the acquisition of an in vitro clinic

DZP advises OW Proton on the acquisition of an in vitro clinic


DZP's client was OW Proton, a financial services and consulting company controlled by Marek Jutkiewicz, an experienced Polish entrepreneur and investor.

With the support of our experts, OW Proton acquired a majority stake in the companies: Medistica Gynaecology + Fertility – an advanced infertility treatment clinic offering specialised assisted reproduction procedures, including IVF, and Medistica Medicine + Beauty – an aesthetic medicine, dermatology and cosmetology clinic.

The two entities are part of the Medistica Medical Group, a dynamically growing family medical group that was founded in 1995 by Dr Mirosław Szlachcic, a renowned expert in gynaecology, obstetrics and endocrinology.

In addition to the share purchase agreement, the shareholders signed a long-term cooperation agreement.

DZP's advice covered comprehensive legal advice on the transaction, including transaction structuring, a due diligence, support in negotiations, full preparation of documentation and transaction closing.

The project was carried out by a multidisciplinary DZP team led by Przemysław Lach and supervised and supported by Robert Niczyporuk. The team included Jakub Rurka, from the Corporate and M&A Practice, Grzegorz Sprawka and Joanna Kociołek-Ziemba from the Tax Practice, and Zuzanna Zapotoczna and Mateusz Mądry from the Life Sciences Practice. Julia Łysik and Anna Okła-Woźniak advised on real estate aspects, while data protection support was provided to the client by Mateusz Jankowski.

Stay updated with DZP